glp 1 agonists how do they work Frontiers PDB-101: Molecule of the Month:
Description
GLP-1 Agonists with SGLT-2 Inhibitors SGLT-2 inhibitors, used in diabetes treatment, may synergize with GLP-1 agonists to enhance weight loss and reduce cardiovascular risk

Furthermore, the cardiovascular benefits emerged early in treatment, preceding significant weight loss, suggesting that the cardiovascular effects may be mediated, at least partially, by other salutary processes in atherosclerotic protection

In more severe or urgent situations, such as with severe IIH, surgical intervention for weight loss is a possible treatment option

Gestational diabetes occurs in relation to pregnancy

Eligible studies investigating the safety (including congenital anomalies, fetal growth, perinatal demise) in animals or humans, or reporting the degree of transfer of these drugs to the fetus, breast milk or breastfed neonate
doi: 10.1172/JCI186652 47 GuarnottaVBiancoMJVigneriEPantoFLo SassoBCiaccioMet al
